| Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis Nature 476 (7359), 214-219, 2011 | 2947 | 2011 |
| Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis International IBD Genetics Consortium (IIBDGC), C Agliardi, L Alfredsson, ... Nature genetics 45 (11), 1353-1360, 2013 | 1327 | 2013 |
| Variants conferring risk of atrial fibrillation on chromosome 4q25 DF Gudbjartsson, DO Arnar, A Helgadottir, S Gretarsdottir, H Holm, ... Nature 448 (7151), 353-357, 2007 | 1069 | 2007 |
| Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity R Roxburgh, SR Seaman, T Masterman, AE Hensiek, SJ Sawcer, ... Neurology 64 (7), 1144-1151, 2005 | 1056 | 2005 |
| The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm A Helgadottir, G Thorleifsson, KP Magnusson, S Grétarsdottir, ... Nature genetics 40 (2), 217-224, 2008 | 856 | 2008 |
| Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility International Multiple Sclerosis Genetics Consortium*†, ANZgene, ... Science 365 (6460), eaav7188, 2019 | 851 | 2019 |
| Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind … G Comi, V Martinelli, M Rodegher, L Moiola, O Bajenaru, A Carra, ... The Lancet 374 (9700), 1503-1511, 2009 | 784 | 2009 |
| Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology N Mullins, AJ Forstner, KS O’Connell, B Coombes, JRI Coleman, Z Qiao, ... Nature genetics 53 (6), 817-829, 2021 | 723 | 2021 |
| Variation in interleukin 7 receptor α chain (IL7R) influences risk of multiple sclerosis F Lundmark, K Duvefelt, E Iacobaeus, I Kockum, E Wallström, M Khademi, ... Nature genetics 39 (9), 1108-1113, 2007 | 621 | 2007 |
| HLA class II‐associated genetic susceptibility in multiple sclerosis: a critical evaluation O Olerup, J Hillert Tissue antigens 38 (2), 1-15, 1991 | 613 | 1991 |
| Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation V Giedraitis, B He, WX Huang, J Hillert Journal of neuroimmunology 112 (1-2), 146-152, 2001 | 605 | 2001 |
| A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke DF Gudbjartsson, H Holm, S Gretarsdottir, G Thorleifsson, GB Walters, ... Nature genetics 41 (8), 876-878, 2009 | 590 | 2009 |
| CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms A Ligers, N Teleshova, T Masterman, WX Huang, J Hillert Genes & Immunity 2 (3), 145-152, 2001 | 457 | 2001 |
| Infection risks among patients with multiple sclerosis treated with fingolimod, natalizumab, rituximab, and injectable therapies G Luna, P Alping, J Burman, K Fink, A Fogdell-Hahn, M Gunnarsson, ... JAMA neurology 77 (2), 184-191, 2020 | 431 | 2020 |
| MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction M Swanberg, O Lidman, L Padyukov, P Eriksson, E Åkesson, M Jagodic, ... Nature genetics 37 (5), 486-494, 2005 | 412 | 2005 |
| Class II HLA interactions modulate genetic risk for multiple sclerosis Nature genetics 47 (10), 1107-1113, 2015 | 394 | 2015 |
| Overexpression of the cytokine BAFF and autoimmunity risk M Steri, V Orrù, ML Idda, M Pitzalis, M Pala, I Zara, C Sidore, V Faà, ... New England Journal of Medicine 376 (17), 1615-1626, 2017 | 378 | 2017 |
| Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring L Kappos, D Bates, G Edan, M Eraksoy, A Garcia-Merino, N Grigoriadis, ... The Lancet Neurology 10 (8), 745-758, 2011 | 374 | 2011 |
| Risk variants for atrial fibrillation on chromosome 4q25 associate with ischemic stroke S Gretarsdottir, G Thorleifsson, A Manolescu, U Styrkarsdottir, ... Annals of neurology 64 (4), 402-409, 2008 | 349 | 2008 |
| HLA‐DR15 is associated with lower age at onset in multiple sclerosis T Masterman, A Ligers, T Olsson, M Andersson, O Olerup, J Hillert Annals of Neurology: Official Journal of the American Neurological …, 2000 | 345 | 2000 |
